A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia

被引：0
|
作者：
Friedman, JI [1 ]
Adler, DN [1 ]
Howanitz, E [1 ]
Harvey, PD [1 ]
Brenner, G [1 ]
Temporini, H [1 ]
White, L [1 ]
Parrella, M [1 ]
Davis, KL [1 ]
机构：
[1] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA
来源：
SCHIZOPHRENIA RESEARCH | 2002年 / 53卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [21] Clozapine augmented with risperidone in the treatment of schizophrenia: A randomized, double-blind, placebo-controlled trial
    Josiassen, RC
    Joseph, A
    Kohegyi, E
    Stokes, S
    Dadvand, M
    Paing, WW
    Shaughnessy, RA
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (01): : 130 - 136
  • [22] A clinical trial of adjunctive estrogen treatment in women with chronic schizophrenia: A double blind and placebo controlled study
    Akhondzadeh, S
    Nejatisafa, AA
    Amini, H
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140
  • [23] Lovastatin for the adjunctive treatment of schizophrenia: A preliminary randomized double-blind placebo-controlled trial
    Ghanizadeh, Ahmad
    Rezaee, Zahra
    Dehbozorgi, Sara
    Berk, Michael
    Akhondzadeh, Shahin
    [J]. PSYCHIATRY RESEARCH, 2014, 219 (03) : 431 - 435
  • [24] Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
    Ghaleiha, Ali
    Asadabadi, Mahtab
    Mohammadi, Mohammad-Reza
    Shahei, Maryam
    Tabrizi, Mina
    Hajiaghaee, Reza
    Hassanzadeh, Elmira
    Akhondzadeh, Shahin
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (04): : 783 - 789
  • [25] Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
    Asadabadi, Mahtab
    Mohammadi, Mohammad-Reza
    Ghanizadeh, Ahmad
    Modabbernia, Amirhossein
    Ashrafi, Mandana
    Hassanzadeh, Elmira
    Forghani, Saeedeh
    Akhondzadeh, Shahin
    [J]. PSYCHOPHARMACOLOGY, 2013, 225 (01) : 51 - 59
  • [26] Minocycline as Adjunctive Treatment to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind Placebo-Controlled Trial
    Ghaleiha, Ali
    Alikhani, Rosa
    Kazemi, Mohammad-Reza
    Mohammadi, Mohammad-Reza
    Mohammadinejad, Payam
    Zeinoddini, Atefeh
    Hamedi, Mehdi
    Shahriari, Mona
    Keshavarzi, Zahra
    Akhondzadeh, Shahin
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2016, 26 (09) : 784 - +
  • [27] Simvastatin as an Adjunctive Therapy to Risperidone in Treatment of Autism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Moazen-Zadeh, Ehsan
    Shirzad, Fatemeh
    Karkhaneh-Yousefi, Mohammad-Ali
    Khezri, Rasoul
    Mohammadi, Mohammad-Reza
    Akhondzadeh, Shahin
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2018, 28 (01) : 82 - 89
  • [28] Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
    Mahtab Asadabadi
    Mohammad-Reza Mohammadi
    Ahmad Ghanizadeh
    Amirhossein Modabbernia
    Mandana Ashrafi
    Elmira Hassanzadeh
    Saeedeh Forghani
    Shahin Akhondzadeh
    [J]. Psychopharmacology, 2013, 225 : 51 - 59
  • [29] Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial
    Pandina, Gahan J.
    Canuso, Carla M.
    Turkoz, Ibrahim
    Kujawa, Mary
    Mahmoud, Ramy A.
    [J]. PSYCHOPHARMACOLOGY BULLETIN, 2007, 40 (03) : 41 - 57
  • [30] Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial
    Joo-Cheol Shim
    Do-Un Jung
    Sung-Soo Jung
    Young-Soo Seo
    Deuk-Man Cho
    Ji-Heon Lee
    Sae-Woom Lee
    Bo-Geum Kong
    Je-Wook Kang
    Min-Kyung Oh
    Sang-Duk Kim
    Robert P McMahon
    Deanna L Kelly
    [J]. Neuropsychopharmacology, 2012, 37 : 660 - 668
12345